Decreased clot burden is associated with factor XIII Val34Leu polymorphism and better functional outcomes in acute ischemic stroke patients treated with intravenous thrombolysis

BACKGROUND: Intravenous thrombolysis using recombinant tissue plasminogen activator remains the mainstay treatment of acute ischemic stroke (AIS), although endovascular treatment is becoming standard of care in case of large vessel occlusions (LVO). To quantify the thrombus burden in LVO, a semiquan...

Descripción completa

Detalles Bibliográficos
Autores principales: Szegedi, István, Orbán-Kálmándi, Rita, Nagy, Attila, Sarkady, Ferenc, Vasas, Nikolett, Sik, Máté, Lánczi, Levente István, Berényi, Ervin, Oláh, László, Crișan, Alexandra, Csiba, László, Bagoly, Zsuzsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263307/
https://www.ncbi.nlm.nih.gov/pubmed/34234378
http://dx.doi.org/10.1371/journal.pone.0254253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263307/
https://www.ncbi.nlm.nih.gov/pubmed/34234378
http://dx.doi.org/10.1371/journal.pone.0254253

Ejemplares similares